#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation
Click to read this study in The Lancet Oncology.
Jan 31, 2023
Click to read this study in The Lancet Oncology.
Jan 31, 2023
Click here to read this study in NEJM
Jan 27, 2023
1. In a randomized clinical trial, internet-delivered parent-child interaction therapy (iPCIT)...
Jan 27, 2023
Overall tumour response to monotherapy treatment with adagrasib was 23% 46% in combination with...
Jan 27, 2023
1. In this randomized clinical trial, among 2859 patients, death occurred in 26.1% of patients...
Jan 25, 2023
Click to read this study in JAMA Oncology.
Jan 24, 2023
Click here to read this study in NEJM
Jan 24, 2023
Click to read this study in JAMA Network Open.
Jan 20, 2023
Click here to read this study in NEJM
Jan 18, 2023
1. Among patients with persistent atrial fibrillation (AF) treated with cardiac ablation, those...
Jan 12, 2023
1. Lecanemab was associated with reduced amyloid markers in early Alzheimer’s disease as compared...
Jan 5, 2023
1. In infants undergoing cardiopulmonary bypass surgery, prophylactic methylprednisolone use did...